vs

Side-by-side financial comparison of Cardlytics, Inc. (CDLX) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.

Cardlytics, Inc. is the larger business by last-quarter revenue ($50.9M vs $31.5M, roughly 1.6× Community Healthcare Trust Inc). On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (4.8% vs -25.5%). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (7.0% CAGR vs -9.6%).

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

CDLX vs CHCT — Head-to-Head

Bigger by revenue
CDLX
CDLX
1.6× larger
CDLX
$50.9M
$31.5M
CHCT
Growing faster (revenue YoY)
CHCT
CHCT
+30.3% gap
CHCT
4.8%
-25.5%
CDLX
Faster 2-yr revenue CAGR
CHCT
CHCT
Annualised
CHCT
7.0%
-9.6%
CDLX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDLX
CDLX
CHCT
CHCT
Revenue
$50.9M
$31.5M
Net Profit
$2.5M
Gross Margin
Operating Margin
-12.0%
Net Margin
8.1%
Revenue YoY
-25.5%
4.8%
Net Profit YoY
60.2%
EPS (diluted)
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDLX
CDLX
CHCT
CHCT
Q1 26
$31.5M
Q4 25
$50.9M
$30.9M
Q3 25
$47.0M
$31.1M
Q2 25
$58.0M
$29.1M
Q1 25
$56.4M
$30.1M
Q4 24
$68.3M
$29.3M
Q3 24
$61.1M
$29.6M
Q2 24
$64.0M
$27.5M
Net Profit
CDLX
CDLX
CHCT
CHCT
Q1 26
$2.5M
Q4 25
$14.4M
Q3 25
$-72.7M
$1.6M
Q2 25
$-9.3M
$-12.6M
Q1 25
$-13.3M
$1.6M
Q4 24
$1.8M
Q3 24
$-145.2M
$1.7M
Q2 24
$-4.3M
$-10.4M
Operating Margin
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
-12.0%
Q3 25
-146.6%
Q2 25
-22.0%
Q1 25
-24.9%
Q4 24
-12.2%
Q3 24
-243.1%
Q2 24
-24.7%
Net Margin
CDLX
CDLX
CHCT
CHCT
Q1 26
8.1%
Q4 25
46.6%
Q3 25
-154.7%
5.3%
Q2 25
-16.0%
-43.2%
Q1 25
-23.5%
5.3%
Q4 24
6.3%
Q3 24
-237.6%
5.9%
Q2 24
-6.7%
-37.9%
EPS (diluted)
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
$-0.15
$0.52
Q3 25
$-1.36
$0.03
Q2 25
$-0.18
$-0.50
Q1 25
$-0.26
$0.03
Q4 24
$-0.36
$0.04
Q3 24
$-2.90
$0.04
Q2 24
$-0.09
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDLX
CDLX
CHCT
CHCT
Cash + ST InvestmentsLiquidity on hand
$48.7M
$2.6M
Total DebtLower is stronger
$212.6M
Stockholders' EquityBook value
$-6.5M
$421.3M
Total Assets
$285.6M
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDLX
CDLX
CHCT
CHCT
Q1 26
$2.6M
Q4 25
$48.7M
$3.3M
Q3 25
$44.0M
$3.4M
Q2 25
$46.7M
$4.9M
Q1 25
$52.0M
$2.3M
Q4 24
$65.6M
$4.4M
Q3 24
$67.0M
$2.8M
Q2 24
$71.2M
$734.0K
Total Debt
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
$212.6M
$532.2M
Q3 25
$214.6M
$530.1M
Q2 25
$214.3M
$500.1M
Q1 25
$213.9M
$496.0M
Q4 24
$213.6M
$486.0M
Q3 24
$213.2M
$473.7M
Q2 24
$212.9M
$457.6M
Stockholders' Equity
CDLX
CDLX
CHCT
CHCT
Q1 26
$421.3M
Q4 25
$-6.5M
$429.4M
Q3 25
$-4.7M
$426.8M
Q2 25
$58.7M
$437.8M
Q1 25
$64.1M
$461.3M
Q4 24
$70.0M
$476.0M
Q3 24
$69.7M
$477.2M
Q2 24
$210.0M
$497.8M
Total Assets
CDLX
CDLX
CHCT
CHCT
Q1 26
$1.0B
Q4 25
$285.6M
$990.8M
Q3 25
$292.8M
$987.3M
Q2 25
$361.1M
$966.3M
Q1 25
$369.1M
$985.1M
Q4 24
$392.7M
$992.6M
Q3 24
$399.4M
$981.8M
Q2 24
$534.4M
$983.2M
Debt / Equity
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
1.24×
Q3 25
1.24×
Q2 25
3.65×
1.14×
Q1 25
3.34×
1.08×
Q4 24
3.05×
1.02×
Q3 24
3.06×
0.99×
Q2 24
1.01×
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDLX
CDLX
CHCT
CHCT
Operating Cash FlowLast quarter
$13.0M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
$13.0M
$56.4M
Q3 25
$1.8M
$12.7M
Q2 25
$1.2M
$13.8M
Q1 25
$-6.7M
$14.4M
Q4 24
$3.0M
$58.9M
Q3 24
$1.4M
$13.8M
Q2 24
$4.4M
$16.7M
Free Cash Flow
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
$13.0M
$35.9M
Q3 25
$1.7M
$7.6M
Q2 25
$903.0K
$9.6M
Q1 25
$-6.8M
$9.7M
Q4 24
$2.9M
$34.2M
Q3 24
$878.0K
$6.7M
Q2 24
$4.1M
$9.5M
FCF Margin
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
25.5%
116.0%
Q3 25
3.7%
24.6%
Q2 25
1.6%
32.9%
Q1 25
-12.1%
32.3%
Q4 24
4.2%
116.9%
Q3 24
1.4%
22.5%
Q2 24
6.5%
34.7%
Capex Intensity
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
0.0%
66.3%
Q3 25
0.0%
16.3%
Q2 25
0.6%
14.5%
Q1 25
0.2%
15.6%
Q4 24
0.2%
84.1%
Q3 24
0.8%
24.2%
Q2 24
0.4%
26.1%
Cash Conversion
CDLX
CDLX
CHCT
CHCT
Q1 26
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons